Health Literacy's Impact on Exercise Habits and Medication Adherence in Postmenopausal Osteoporosis
Recruiting
Observational Study
Osteoporosis, Postmenopausal
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 45 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- Gazi University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Postmenopausal osteoporosis is characterized by low bone mass and increased fracture risk. Treatment includes exercise, nutrition, supplements, and medications like bisphosphonates, denosumab, or hormone replacement therapy. Lifestyle changes such as quitting smoking, reducing alcohol consumption, and preventing falls are also crucial.
Despite effective treatments, adherence is low: 20-30% of pat…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Postmenopausal patients
* Being under outpatient follow-up for osteoporosis for at least one year
Exclusion Criteria:
* Orthopedic, rheumatic, and neurological conditions that may hinder participation in exercise
* Cancer
* Refusal to participate in the study
Contacts